Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1031-1040 of 1,467) with videos related to

Pageof 147
Sort By:
Journal of Cellular and Molecular Medicine|August 23, 2018
CCR6 controls autoimmune but not innate immunity-driven experimental arthritisMichael Bonelli, Antonia Puchner, Lisa Göschl, et al.
Mbio|April 21, 2022
Plasma Proteomic Analysis Distinguishes Severity Outcomes of Human Ebola Virus DiseaseArthur Viodé, Kinga K Smolen, Benoit Fatou, et al.
Expert Review of Clinical Immunology|January 13, 2025
Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 studyGerd Burmester, Piotr Adrian Klimiuk, Jakub Trefler, et al.
Nature Reviews. Disease Primers|February 9, 2018
Rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Anne Barton, et al.
Health and Quality of Life Outcomes|April 17, 2015
Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of referenceMona Dür, Michaela Coenen, Michaela Alexandra Stoffer, et al.
Journal of Hepatology|March 8, 2020
Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitisLaura Weichselbaum, Abdulkader Azouz, Kinga K Smolen, et al.
Annals of the Rheumatic Diseases|March 31, 2012
Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160Josef S Smolen, Jonathan Kay, Robert B M Landewé, et al.
Annals of the Rheumatic Diseases|March 31, 2017
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisKaterina Chatzidionysiou, Sharzad Emamikia, Jackie Nam, et al.
Neurochemistry International|October 4, 2024
The evolving pathophysiology of TBI and the advantages of temporally-guided combination therapiesLaura Zima, Anthony N Moore, Paul Smolen, et al.
Journal of Crohn'S & Colitis|February 5, 2013
Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeingMona Dür, Martina Sadloňová, Stefanie Haider, et al.
Pageof 147

Showing results (1031-1040 of 1,467) with videos related to

Sort By:
Pageof 147
Journal of Cellular and Molecular Medicine|August 23, 2018
CCR6 controls autoimmune but not innate immunity-driven experimental arthritisMichael Bonelli, Antonia Puchner, Lisa Göschl, et al.
Mbio|April 21, 2022
Plasma Proteomic Analysis Distinguishes Severity Outcomes of Human Ebola Virus DiseaseArthur Viodé, Kinga K Smolen, Benoit Fatou, et al.
Expert Review of Clinical Immunology|January 13, 2025
Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 studyGerd Burmester, Piotr Adrian Klimiuk, Jakub Trefler, et al.
Nature Reviews. Disease Primers|February 9, 2018
Rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Anne Barton, et al.
Health and Quality of Life Outcomes|April 17, 2015
Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of referenceMona Dür, Michaela Coenen, Michaela Alexandra Stoffer, et al.
Journal of Hepatology|March 8, 2020
Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitisLaura Weichselbaum, Abdulkader Azouz, Kinga K Smolen, et al.
Annals of the Rheumatic Diseases|March 31, 2012
Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160Josef S Smolen, Jonathan Kay, Robert B M Landewé, et al.
Annals of the Rheumatic Diseases|March 31, 2017
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisKaterina Chatzidionysiou, Sharzad Emamikia, Jackie Nam, et al.
Neurochemistry International|October 4, 2024
The evolving pathophysiology of TBI and the advantages of temporally-guided combination therapiesLaura Zima, Anthony N Moore, Paul Smolen, et al.
Journal of Crohn'S & Colitis|February 5, 2013
Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeingMona Dür, Martina Sadloňová, Stefanie Haider, et al.
Pageof 147